BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Momtazmanesh S, Zare-Shahabadi A, Rezaei N. Cytokine Alterations in Schizophrenia: An Updated Review. Front Psychiatry 2019;10:892. [PMID: 31908647 DOI: 10.3389/fpsyt.2019.00892] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 16.3] [Reference Citation Analysis]
Number Citing Articles
1 Afia AB, Vila È, MacDowell KS, Ormazabal A, Leza JC, Haro JM, Artuch R, Ramos B, Garcia-Bueno B. Kynurenine pathway in post-mortem prefrontal cortex and cerebellum in schizophrenia: relationship with monoamines and symptomatology. J Neuroinflammation 2021;18:198. [PMID: 34511126 DOI: 10.1186/s12974-021-02260-6] [Reference Citation Analysis]
2 Klaus F, Mitchell K, Liou SC, Eyler LT, Nguyen TT. Chemokine MCP1 is associated with cognitive flexibility in schizophrenia: A preliminary analysis. J Psychiatr Res 2021;138:139-45. [PMID: 33852994 DOI: 10.1016/j.jpsychires.2021.04.007] [Reference Citation Analysis]
3 Murphy CE, Walker AK, O'Donnell M, Galletly C, Lloyd AR, Liu D, Weickert CS, Weickert TW. Peripheral NF-κB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-κB kinases. Transl Psychiatry 2022;12:21. [PMID: 35027554 DOI: 10.1038/s41398-021-01764-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Morozova A, Zorkina Y, Pavlov K, Pavlova O, Abramova O, Ushakova V, Mudrak AV, Zozulya S, Otman I, Sarmanova Z, Klyushnik T, Reznik A, Kostyuk G, Chekhonin V. Associations of Genetic Polymorphisms and Neuroimmune Markers With Some Parameters of Frontal Lobe Dysfunction in Schizophrenia. Front Psychiatry 2021;12:655178. [PMID: 34025476 DOI: 10.3389/fpsyt.2021.655178] [Reference Citation Analysis]
5 Larsen JB, Reitan SK, Løberg EM, Rettenbacher M, Bruserud Ø, Larsen TK, Anda L, Bartz-Johannessen C, Johnsen E, Kroken RA. The association between cytokines and psychomotor speed in a spectrum of psychotic disorders: A longitudinal study. Brain Behav Immun Health 2021;18:100392. [PMID: 34877553 DOI: 10.1016/j.bbih.2021.100392] [Reference Citation Analysis]
6 Mednova IA, Boiko AS, Kornetova EG, Parshukova DA, Semke AV, Bokhan NA, Loonen AJM, Ivanova SA. Adipocytokines and Metabolic Syndrome in Patients with Schizophrenia. Metabolites 2020;10:E410. [PMID: 33066473 DOI: 10.3390/metabo10100410] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Fan Y, Gao Y, Ma Q, Yang Z, Zhao B, He X, Yang J, Yan B, Gao F, Qian L, Wang W, Zhu F, Ma X. Multi-Omics Analysis Reveals Aberrant Gut-Metabolome-Immune Network in Schizophrenia. Front Immunol 2022;13:812293. [PMID: 35309369 DOI: 10.3389/fimmu.2022.812293] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
8 Cha HY, Yang SJ. Anti-Inflammatory Diets and Schizophrenia.Clin Nutr Res. 2020;9:241-257. [PMID: 33204665 DOI: 10.7762/cnr.2020.9.4.241] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Jung YJ, Tweedie D, Scerba MT, Kim DS, Palmas MF, Pisanu A, Carta AR, Greig NH. Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders. Front Neurosci 2021;15:656921. [PMID: 33854417 DOI: 10.3389/fnins.2021.656921] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Shen H, Zhang L, Li Y, Zheng D, Du L, Xu F, Xu C, Liu Y, Shen J, Li Z, Cui D. Mindfulness-based intervention improves residual negative symptoms and cognitive impairment in schizophrenia: a randomized controlled follow-up study. Psychol Med . [DOI: 10.1017/s0033291721002944] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Li Z, Li X, Jin M, Liu Y, He Y, Jia N, Cui X, Liu Y, Hu G, Yu Q. Identification of potential blood biomarkers for early diagnosis of schizophrenia through RNA sequencing analysis. J Psychiatr Res 2022;147:39-49. [PMID: 35016150 DOI: 10.1016/j.jpsychires.2022.01.003] [Reference Citation Analysis]
12 Ferrari M, Godio M, Martini S, Callegari C, Cosentino M, Marino F. Effect of quetiapine on inflammation and immunity: a systematic review. Int J Psychiatry Clin Pract 2022;:1-12. [PMID: 35913757 DOI: 10.1080/13651501.2022.2101928] [Reference Citation Analysis]
13 Yan J, Chen Y, Ju P, Gao J, Zhang L, Li J, Wang K, Zhang J, Li C, Xia Q, Zhu C, Zhang X. Network Association of Biochemical and Inflammatory Abnormalities With Psychiatric Symptoms in First-Episode Schizophrenia Patients. Front Psychiatry 2022;13:834539. [PMID: 35273531 DOI: 10.3389/fpsyt.2022.834539] [Reference Citation Analysis]
14 Prestwood TR, Asgariroozbehani R, Wu S, Agarwal SM, Logan RW, Ballon JS, Hahn MK, Freyberg Z. Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia. Behav Brain Res 2021;402:113101. [PMID: 33453341 DOI: 10.1016/j.bbr.2020.113101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Michalczyk A, Tyburski E, Podwalski P, Waszczuk K, Rudkowski K, Kucharska-mazur J, Mak M, Rek-owodziń K, Plichta P, Bielecki M, Andrusewicz W, Cecerska-heryć E, Samochowiec A, Misiak B, Sagan L, Samochowiec J. Serum inflammatory markers and their associations with white matter integrity of the corpus callosum in schizophrenia patients and healthy controls. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2022. [DOI: 10.1016/j.pnpbp.2022.110510] [Reference Citation Analysis]
16 Kozłowska E, Brzezińska-Błaszczyk E, Agier J, Wysokiński A, Żelechowska P. Alarmins (IL-33, sST2, HMGB1, and S100B) as potential biomarkers for schizophrenia. J Psychiatr Res 2021;138:380-7. [PMID: 33957300 DOI: 10.1016/j.jpsychires.2021.04.019] [Reference Citation Analysis]
17 Germann M, Brederoo SG, Sommer IEC. Abnormal synaptic pruning during adolescence underlying the development of psychotic disorders. Curr Opin Psychiatry 2021;34:222-7. [PMID: 33560023 DOI: 10.1097/YCO.0000000000000696] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Feng T, McEvoy JP, Miller BJ. Longitudinal study of inflammatory markers and psychopathology in schizophrenia. Schizophr Res 2020;224:58-66. [PMID: 33289658 DOI: 10.1016/j.schres.2020.10.003] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Zhao F, Li B, Yang W, Ge T, Cui R. Brain-immune interaction mechanisms: Implications for cognitive dysfunction in psychiatric disorders. Cell Prolif 2022;:e13295. [PMID: 35860850 DOI: 10.1111/cpr.13295] [Reference Citation Analysis]
20 Ermakov EA, Dmitrieva EM, Parshukova DA, Kazantseva DV, Vasilieva AR, Smirnova LP. Oxidative Stress-Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives. Oxid Med Cell Longev 2021;2021:8881770. [PMID: 33552387 DOI: 10.1155/2021/8881770] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
21 Zhou X, Tian B, Han HB. Serum interleukin-6 in schizophrenia: A system review and meta-analysis. Cytokine 2021;141:155441. [PMID: 33529887 DOI: 10.1016/j.cyto.2021.155441] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Koricanac A, Tomic Lucic A, Veselinovic M, Bazic Sretenovic D, Bucic G, Azanjac A, Radmanovic O, Matovic M, Stanojevic M, Jurisic Skevin A, Simovic Markovic B, Pantic J, Arsenijevic N, Radosavljevic GD, Nikolic M, Zornic N, Nesic J, Muric N, Radmanovic B. Influence of antipsychotics on metabolic syndrome risk in patients with schizophrenia. Front Psychiatry 2022;13:925757. [DOI: 10.3389/fpsyt.2022.925757] [Reference Citation Analysis]
23 Căpățînă OO, Micluția IV, Fadgyas-Stănculete M. Current perspectives in treating negative symptoms of schizophrenia: A narrative review (Review). Exp Ther Med 2021;21:276. [PMID: 33603883 DOI: 10.3892/etm.2021.9707] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Aytac HM, Ozdilli K, Tuncel FC, Pehlivan M, Pehlivan S. Tumor Necrosis Factor-alpha (TNF-α) −238 G/A Polymorphism Is Associated with the Treatment Resistance and Attempted Suicide in Schizophrenia. Immunological Investigations. [DOI: 10.1080/08820139.2020.1832115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Kiliç F, Işik Ü, Usta A, Demirdaş A. Serum tumor necrosis factor-like weak inducer of apoptosis levels are elevated in schizophrenia. Braz J Psychiatry 2021;43:242-6. [PMID: 32785454 DOI: 10.1590/1516-4446-2020-0950] [Reference Citation Analysis]
26 Agustini B, Berk M. The embryology of psychosis. Lancet Psychiatry 2020;7:219-20. [PMID: 32035029 DOI: 10.1016/S2215-0366(20)30042-0] [Reference Citation Analysis]
27 Ermakov EA, Melamud MM, Buneva VN, Ivanova SA. Immune System Abnormalities in Schizophrenia: An Integrative View and Translational Perspectives. Front Psychiatry 2022;13:880568. [PMID: 35546942 DOI: 10.3389/fpsyt.2022.880568] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Ordak M, Libman-Sokolowska M, Nasierowski T, Badyra B, Kaczmarek L, Muszynska E, Bujalska-Zadrozny M. Matrix metalloproteinase-3 serum levels in schizophrenic patients. Int J Psychiatry Clin Pract 2022;:1-7. [PMID: 35357267 DOI: 10.1080/13651501.2022.2057332] [Reference Citation Analysis]
29 Rittmannsberger H, Barth M, Malik P, Malsiner-Walli G, Yazdi K. First-episode psychotic disorders in the wake of the COVID-19 pandemic: a descriptive review of casereports. Acta Neuropsychiatr 2022;:1-22. [PMID: 35357298 DOI: 10.1017/neu.2022.11] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Blagburn-blanco SV, Chappell MS, De Biase LM, Denardo LA. Synapse-specific roles for microglia in development: New horizons in the prefrontal cortex. Front Mol Neurosci 2022;15:965756. [DOI: 10.3389/fnmol.2022.965756] [Reference Citation Analysis]
31 Reddaway J, Brydges NM. Enduring neuroimmunological consequences of developmental experiences: From vulnerability to resilience. Mol Cell Neurosci 2020;109:103567. [PMID: 33068720 DOI: 10.1016/j.mcn.2020.103567] [Reference Citation Analysis]
32 Gao J, Wei Q, Pan R, Yi W, Xu Z, Duan J, Tang C, He Y, Liu X, Song S, Su H. Elevated environmental PM2.5 increases risk of schizophrenia relapse: Mediation of inflammatory cytokines. Science of The Total Environment 2021;753:142008. [DOI: 10.1016/j.scitotenv.2020.142008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
33 De Hert M, Mazereel V, Stroobants M, De Picker L, Van Assche K, Detraux J. COVID-19-Related Mortality Risk in People With Severe Mental Illness: A Systematic and Critical Review. Front Psychiatry 2021;12:798554. [PMID: 35095612 DOI: 10.3389/fpsyt.2021.798554] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
34 Chaves Filho AJM, Mottin M, Soares MV, Jucá PM, Andrade CH, Macedo DS. Tetracyclines, a promise for neuropsychiatric disorders: from adjunctive therapy to the discovery of new targets for rational drug design in psychiatry. Behav Pharmacol 2021;32:123-41. [PMID: 33595954 DOI: 10.1097/FBP.0000000000000585] [Reference Citation Analysis]
35 Chauhan P, Kaur G, Prasad R, Singh H. Pharmacotherapy of schizophrenia: immunological aspects and potential role of immunotherapy. Expert Rev Neurother 2021;:1-13. [PMID: 34654348 DOI: 10.1080/14737175.2021.1994857] [Reference Citation Analysis]
36 Nadalin S, Jakovac H, Peitl V, Karlović D, Buretić-Tomljanović A. Dysregulated inflammation may predispose patients with serious mental illnesses to severe COVID‑19 (Review). Mol Med Rep 2021;24:611. [PMID: 34184073 DOI: 10.3892/mmr.2021.12250] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Wang C, Zhang T, He L, Fu JY, Deng HX, Xue XL, Chen BT. Bacterial Translocation Associates With Aggression in Schizophrenia Inpatients. Front Syst Neurosci 2021;15:704069. [PMID: 34658801 DOI: 10.3389/fnsys.2021.704069] [Reference Citation Analysis]
38 Dawidowski B, Górniak A, Podwalski P, Lebiecka Z, Misiak B, Samochowiec J. The Role of Cytokines in the Pathogenesis of Schizophrenia. J Clin Med 2021;10:3849. [PMID: 34501305 DOI: 10.3390/jcm10173849] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
39 Cyrino LAR, Delwing-de Lima D, Ullmann OM, Maia TP. Concepts of Neuroinflammation and Their Relationship With Impaired Mitochondrial Functions in Bipolar Disorder. Front Behav Neurosci 2021;15:609487. [PMID: 33732117 DOI: 10.3389/fnbeh.2021.609487] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 He S, Zhang L, Yu S, Yu W, Yu Y, Huang J, Li H. Association between Tumor Necrosis factor-Alpha(TNF-a) polymorphisms and Schizophrenia: an updated meta-analysis. Int J Psychiatry Clin Pract 2022;:1-9. [PMID: 35188044 DOI: 10.1080/13651501.2021.2009879] [Reference Citation Analysis]
41 Seyedmirzaei H, Rezaei N. Cytokine alterations in psoriasis: an updated review. Expert Rev Clin Immunol 2021;17:1323-35. [PMID: 34845948 DOI: 10.1080/1744666X.2022.2011720] [Reference Citation Analysis]
42 Zhu H, Yang Y, Zhu M, Shi X, Ye L, Zhang S, Fang H, Yu W. Alteration in the expression of inflammatory cytokines in primary hippocampal astrocytes in response to MK-801 through ERK1/2 and PI3K signals. Cytokine 2021;138:155366. [PMID: 33187817 DOI: 10.1016/j.cyto.2020.155366] [Reference Citation Analysis]
43 Robinson N, Bergen SE. Environmental Risk Factors for Schizophrenia and Bipolar Disorder and Their Relationship to Genetic Risk: Current Knowledge and Future Directions. Front Genet 2021;12:686666. [PMID: 34262598 DOI: 10.3389/fgene.2021.686666] [Reference Citation Analysis]
44 Miola A, Dal Porto V, Tadmor T, Croatto G, Scocco P, Manchia M, Carvalho AF, Maes M, Vieta E, Sambataro F, Solmi M. Increased C-reactive protein concentration and suicidal behavior in people with psychiatric disorders: A systematic review and meta-analysis. Acta Psychiatr Scand 2021;144:537-52. [PMID: 34292580 DOI: 10.1111/acps.13351] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
45 Ramos-Méndez MA, Tovilla-Zárate CA, Juárez-Rojop IE, Villar-Soto M, Genis-Mendoza AD, González-Castro TB, López-Narváez ML, Martínez-Magaña JJ, Castillo-Avila RG, Villar-Juárez GE. Effect of risperidone on serum IL-6 levels in individuals with schizophrenia: a systematic review and meta-analysis. Int J Psychiatry Clin Pract 2022;:1-8. [PMID: 35839173 DOI: 10.1080/13651501.2022.2100264] [Reference Citation Analysis]
46 Ramos-Martínez IE, Rodríguez MC, Cerbón M, Ramos-Martínez JC, Ramos-Martínez EG. Role of the Cholinergic Anti-Inflammatory Reflex in Central Nervous System Diseases. Int J Mol Sci 2021;22:13427. [PMID: 34948222 DOI: 10.3390/ijms222413427] [Reference Citation Analysis]
47 Zhou YY, Zhang WW, Chen F, Hu SS, Jiang HY. Maternal infection exposure and the risk of psychosis in the offspring: A systematic review and meta-analysis. J Psychiatr Res 2021;135:28-36. [PMID: 33445058 DOI: 10.1016/j.jpsychires.2020.12.065] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Bigseth TT, Engh JA, Egeland J, Andersen E, Andreassen OA, Bang-Kittilsen G, Falk RS, Holmen TL, Lindberg M, Mordal J, Nielsen J, Steen NE, Ueland T, Vang T, Fredriksen M. Exploring low grade inflammation by soluble urokinase plasminogen activator receptor levels in schizophrenia: a sex-dependent association with depressive symptoms. BMC Psychiatry 2021;21:527. [PMID: 34702245 DOI: 10.1186/s12888-021-03522-6] [Reference Citation Analysis]
49 Räuber S, Heming M, Repple J, Ruland T, Kuelby R, Schulte-Mecklenbeck A, Gross CC, Arolt V, Baune B, Hahn T, Dannlowski U, Meuth SG, Melzer N, Wiendl H, Meyer Zu Hörste G. Cerebrospinal fluid flow cytometry distinguishes psychosis spectrum disorders from differential diagnoses. Mol Psychiatry 2021. [PMID: 34363013 DOI: 10.1038/s41380-021-01244-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Ma H, Cheng N, Zhang C. Schizophrenia and Alarmins. Medicina (Kaunas) 2022;58:694. [PMID: 35743957 DOI: 10.3390/medicina58060694] [Reference Citation Analysis]
51 Jeong SH, Kim YS. Challenges in Prescribing Clozapine in the Era of COVID-19: A Review Focused on Immunological Implications. Clin Psychopharmacol Neurosci 2021;19:411-22. [PMID: 34294611 DOI: 10.9758/cpn.2021.19.3.411] [Reference Citation Analysis]
52 Bellman V, Russell N, Depala K, Dellenbaugh A, Desai S, Vadukapuram R, Patel S, Srinivas S. Challenges in Treating Cancer Patients With Unstable Psychiatric Disorder. World J Oncol 2021;12:137-48. [PMID: 34804276 DOI: 10.14740/wjon1402] [Reference Citation Analysis]
53 de Bartolomeis A, Barone A, Begni V, Riva MA. Present and future antipsychotic drugs: a systematic review of the putative mechanisms of action for efficacy and a critical appraisal under a translational perspective. Pharmacol Res 2022;:106078. [PMID: 35026403 DOI: 10.1016/j.phrs.2022.106078] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Dawidowski B, Grelecki G, Biłgorajski A, Podwalski P, Misiak B, Samochowiec J. Effect of Antipsychotic Treatment on Neutrophil-to-Lymphocyte Ratio during Hospitalization for Acute Psychosis in the Course of Schizophrenia-A Cross-Sectional Retrospective Study. J Clin Med 2021;11:232. [PMID: 35011972 DOI: 10.3390/jcm11010232] [Reference Citation Analysis]
55 Heurich M, Föcking M, Mongan D, Cagney G, Cotter DR. Dysregulation of complement and coagulation pathways: emerging mechanisms in the development of psychosis. Mol Psychiatry 2021. [PMID: 34226666 DOI: 10.1038/s41380-021-01197-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
56 Reale M, Costantini E, Greig NH. Cytokine Imbalance in Schizophrenia. From Research to Clinic: Potential Implications for Treatment. Front Psychiatry 2021;12:536257. [PMID: 33746786 DOI: 10.3389/fpsyt.2021.536257] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
57 Labonté C, Zhand N, Park A, Harvey PD. Complete blood count inflammatory markers in treatment-resistant schizophrenia: Evidence of association between treatment responsiveness and levels of inflammation. Psychiatry Res 2021;308:114382. [PMID: 34995832 DOI: 10.1016/j.psychres.2021.114382] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Chen M, Wang W, Song W, Qian W, Lin GN. Integrative Analysis Identified Key Schizophrenia Risk Factors from an Abnormal Behavior Mouse Gene Set. Life (Basel) 2021;11:172. [PMID: 33672431 DOI: 10.3390/life11020172] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Smail MA, Reigle JK, McCullumsmith RE. Using protein turnover to expand the applications of transcriptomics. Sci Rep 2021;11:4403. [PMID: 33623108 DOI: 10.1038/s41598-021-83886-7] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
60 Liang Y, Shi X, Shen Y, Huang Z, Wang J, Shao C, Chu Y, Chen J, Yu J, Kang Y. Enhanced intestinal protein fermentation in schizophrenia. BMC Med 2022;20:67. [PMID: 35135531 DOI: 10.1186/s12916-022-02261-z] [Reference Citation Analysis]
61 Eissa N, Sadeq A, Sasse A, Sadek B. Role of Neuroinflammation in Autism Spectrum Disorder and the Emergence of Brain Histaminergic System. Lessons Also for BPSD? Front Pharmacol 2020;11:886. [PMID: 32612529 DOI: 10.3389/fphar.2020.00886] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
62 Bonkat N, Fellendorf FT, Dalkner N, Reininghaus EZ. Severe mental disorders and vaccinations - a systematic review. World J Biol Psychiatry 2022;:1-16. [PMID: 35014937 DOI: 10.1080/15622975.2021.2013095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Novellino F, Saccà V, Donato A, Zaffino P, Spadea MF, Vismara M, Arcidiacono B, Malara N, Presta I, Donato G. Innate Immunity: A Common Denominator between Neurodegenerative and Neuropsychiatric Diseases. Int J Mol Sci 2020;21:E1115. [PMID: 32046139 DOI: 10.3390/ijms21031115] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 15.5] [Reference Citation Analysis]
64 Nemani K, Li C, Olfson M, Blessing EM, Razavian N, Chen J, Petkova E, Goff DC. Association of Psychiatric Disorders With Mortality Among Patients With COVID-19. JAMA Psychiatry 2021;78:380-6. [PMID: 33502436 DOI: 10.1001/jamapsychiatry.2020.4442] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 49.0] [Reference Citation Analysis]
65 Jutla A, Foss-Feig J, Veenstra-VanderWeele J. Autism spectrum disorder and schizophrenia: An updated conceptual review. Autism Res 2021. [PMID: 34967130 DOI: 10.1002/aur.2659] [Reference Citation Analysis]
66 Chen L, Zheng WH, Du Y, Li XS, Yu Y, Wang H, Cheng Y. Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications. Front Med (Lausanne) 2021;8:757655. [PMID: 34901070 DOI: 10.3389/fmed.2021.757655] [Reference Citation Analysis]
67 Scorza FA, de Almeida AG, Scorza CA, Cysneiros RM, Rodrigues AM, Finsterer J. Interleukin-6 in schizophrenia: Cause of death matters. Brain Behav Immun 2020;90:381-2. [PMID: 32889081 DOI: 10.1016/j.bbi.2020.08.033] [Reference Citation Analysis]
68 Lorenzo-Villalba N, Jannot X, Syrovatkova A, Michel V, Andrès E. SARS-CoV-2 infection and psychiatric manifestations in a previous healthy patient. Caspian J Intern Med 2020;11:566-8. [PMID: 33425277 DOI: 10.22088/cjim.11.0.566] [Reference Citation Analysis]
69 Thompson AD, Jones HJ, Heron J, Hibbeln J, Sullivan S, Zammit S. Omega-3 and Omega-6 fatty acids and risk of psychotic outcomes in the ALSPAC birth cohort. Schizophr Res 2020;224:108-15. [PMID: 33067055 DOI: 10.1016/j.schres.2020.09.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
70 Morris G, Puri BK, Olive L, Carvalho A, Berk M, Walder K, Gustad LT, Maes M. Endothelial dysfunction in neuroprogressive disorders-causes and suggested treatments. BMC Med 2020;18:305. [PMID: 33070778 DOI: 10.1186/s12916-020-01749-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
71 Rajkumar RP. The DOSMD challenge and the COVID-19 conundrum. Schizophr Res 2020;222:475-6. [PMID: 32553434 DOI: 10.1016/j.schres.2020.06.010] [Reference Citation Analysis]
72 Gammon D, Cheng C, Volkovinskaia A, Baker GB, Dursun SM. Clozapine: Why Is It So Uniquely Effective in the Treatment of a Range of Neuropsychiatric Disorders? Biomolecules 2021;11:1030. [PMID: 34356654 DOI: 10.3390/biom11071030] [Reference Citation Analysis]
73 Dunleavy C, Elsworthy RJ, Upthegrove R, Wood SJ, Aldred S. Inflammation in first-episode psychosis: The contribution of inflammatory biomarkers to the emergence of negative symptoms, a systematic review and meta-analysis. Acta Psychiatr Scand 2022. [PMID: 35202480 DOI: 10.1111/acps.13416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
74 Bryll A, Skrzypek J, Krzyściak W, Szelągowska M, Śmierciak N, Kozicz T, Popiela T. Oxidative-Antioxidant Imbalance and Impaired Glucose Metabolism in Schizophrenia. Biomolecules 2020;10:E384. [PMID: 32121669 DOI: 10.3390/biom10030384] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
75 Gao Y, Fan Y, Yang Z, Ma Q, Zhao B, He X, Gao F, Qian L, Wang W, Chen C, Chen Y, Gao C, Ma X, Zhu F. Systems biological assessment of altered cytokine responses to bacteria and fungi reveals impaired immune functionality in schizophrenia. Mol Psychiatry 2021. [PMID: 34728799 DOI: 10.1038/s41380-021-01362-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
76 Welcome MO, Mastorakis NE. The taste of neuroinflammation: Molecular mechanisms linking taste sensing to neuroinflammatory responses. Pharmacol Res 2021;167:105557. [PMID: 33737243 DOI: 10.1016/j.phrs.2021.105557] [Reference Citation Analysis]
77 Bohmwald K, Andrade CA, Kalergis AM. Contribution of Pro-Inflammatory Molecules Induced by Respiratory Virus Infections to Neurological Disorders. Pharmaceuticals (Basel) 2021;14:340. [PMID: 33917837 DOI: 10.3390/ph14040340] [Reference Citation Analysis]
78 Kose M, Pariante CM, Dazzan P, Mondelli V. The Role of Peripheral Inflammation in Clinical Outcome and Brain Imaging Abnormalities in Psychosis: A Systematic Review. Front Psychiatry 2021;12:612471. [PMID: 33679475 DOI: 10.3389/fpsyt.2021.612471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
79 Kummer KK, Zeidler M, Kalpachidou T, Kress M. Role of IL-6 in the regulation of neuronal development, survival and function. Cytokine 2021;144:155582. [PMID: 34058569 DOI: 10.1016/j.cyto.2021.155582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]